25.01
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BEAM Giù?
Forum
Previsione
Precedente Chiudi:
$23.80
Aprire:
$23.8
Volume 24 ore:
3.59M
Relative Volume:
1.36
Capitalizzazione di mercato:
$2.53B
Reddito:
$352.57M
Utile/perdita netta:
$-143.01M
Rapporto P/E:
-13.82
EPS:
-1.81
Flusso di cassa netto:
$-153.40M
1 W Prestazione:
-10.55%
1M Prestazione:
+3.05%
6M Prestazione:
+25.49%
1 anno Prestazione:
+14.15%
Beam Therapeutics Inc Stock (BEAM) Company Profile
Nome
Beam Therapeutics Inc
Settore
Industria
Telefono
857-327-8775
Indirizzo
26 LANDSDOWNE STREET, CAMBRIDGE, MA
Confronta BEAM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
BEAM
Beam Therapeutics Inc
|
25.01 | 2.41B | 352.57M | -143.01M | -153.40M | -1.81 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Beam Therapeutics Inc Stock (BEAM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-09 | Iniziato | Jefferies | Buy |
| 2025-03-28 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2025-03-10 | Aggiornamento | Scotiabank | Sector Perform → Sector Outperform |
| 2025-01-29 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2024-11-06 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2024-10-16 | Iniziato | Scotiabank | Sector Outperform |
| 2024-07-23 | Iniziato | H.C. Wainwright | Buy |
| 2024-01-29 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2023-12-15 | Downgrade | BofA Securities | Buy → Neutral |
| 2023-12-08 | Downgrade | Jefferies | Buy → Hold |
| 2023-10-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2023-10-20 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2023-03-21 | Iniziato | Bernstein | Mkt Perform |
| 2023-02-01 | Iniziato | Cantor Fitzgerald | Overweight |
| 2022-12-20 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
| 2022-12-13 | Iniziato | Citigroup | Buy |
| 2022-06-17 | Iniziato | BMO Capital Markets | Market Perform |
| 2022-04-28 | Iniziato | Credit Suisse | Neutral |
| 2022-01-05 | Iniziato | Guggenheim | Buy |
| 2021-10-19 | Iniziato | SVB Leerink | Outperform |
| 2021-09-24 | Ripresa | Stifel | Buy |
| 2021-09-10 | Iniziato | BofA Securities | Buy |
| 2021-05-11 | Iniziato | Redburn | Buy |
| 2021-05-04 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2021-03-01 | Downgrade | Barclays | Overweight → Equal Weight |
| 2021-02-16 | Iniziato | Wells Fargo | Overweight |
| 2021-01-29 | Downgrade | JP Morgan | Overweight → Neutral |
| 2021-01-06 | Iniziato | Stifel | Hold |
| 2020-08-05 | Iniziato | William Blair | Outperform |
| 2020-03-02 | Iniziato | Barclays | Overweight |
| 2020-03-02 | Iniziato | JP Morgan | Overweight |
| 2020-03-02 | Iniziato | Jefferies | Buy |
| 2020-03-02 | Iniziato | Wedbush | Outperform |
Mostra tutto
Beam Therapeutics Inc Borsa (BEAM) Ultime notizie
Institutional scanner results for Beam Therapeutics Inc.2025 Market Sentiment & Breakout Confirmation Trade Signals - newser.com
Why retail investors favor Beam Therapeutics Inc. stockTrade Ideas & Weekly Breakout Opportunity Watchlist - newser.com
Published on: 2025-11-02 01:58:11 - newser.com
Real time social sentiment graph for Beam Therapeutics Inc.July 2025 Movers & Expert Approved Momentum Ideas - newser.com
How to monitor Beam Therapeutics Inc. with trend dashboardsTrade Analysis Summary & Safe Capital Growth Tips - newser.com
Why Beam Therapeutics Inc. stock is favored by pension fundsQuarterly Performance Summary & Fast Moving Market Watchlists - newser.com
Will Beam Therapeutics Inc. stock deliver long term returnsPortfolio Profit Report & Weekly Top Performers Watchlists - newser.com
Should you wait for a breakout in Beam Therapeutics Inc.Sell Signal & Free Weekly Chart Analysis and Trade Guides - newser.com
How buybacks impact Beam Therapeutics Inc. stock valueTrade Signal Summary & AI Forecasted Entry/Exit Points - newser.com
Will Beam Therapeutics Inc. stock outperform Nasdaq indexInsider Buying & Stepwise Trade Signal Guides - newser.com
What hedge fund activity signals for Beam Therapeutics Inc. stockJuly 2025 Snapshot & Reliable Entry Point Trade Alerts - newser.com
Published on: 2025-10-31 03:50:40 - newser.com
Visualizing Beam Therapeutics Inc. stock with heatmaps2025 Institutional Moves & Daily Chart Pattern Signals - newser.com
ETFs Investing in Beam Therapeutics Inc. Stocks - TradingView
Why retail investors pile into Beam Therapeutics Inc. stockTreasury Yields & Real-Time Volume Triggers - newser.com
Beam Therapeutics Inc. (BEAM) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Beam Therapeutics Inc. (BEAM) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Fmr Llc Sells 459 Shares of Beam Therapeutics (NASDAQ:BEAM) Stock - MarketBeat
Visual analytics tools that track Beam Therapeutics Inc. performanceIPO Watch & Advanced Swing Trade Entry Plans - newser.com
BEAM Form 4: 459-share sale; indirect holdings include 1,139,443 - Stock Titan
Beam Therapeutics (BEAM) Could Find a Support Soon, Here's Why You Should Buy the Stock Now - sharewise.com
Beam Therapeutics (BEAM) Expected to Announce Quarterly Earnings on Tuesday - MarketBeat
What is the fair value of Beam Therapeutics Inc. stock nowEarnings Summary Report & Weekly Top Gainers Alerts - newser.com
Beam Therapeutics Stock Dropped 13%Have You Assessed the Risk - Trefis
Beam Therapeutics (NASDAQ:BEAM) Shares Gap DownHere's Why - MarketBeat
Beam Therapeutics Inc. (BEAM) May Report Negative Earnings: Know the Trend Ahead of Q3 Release - Yahoo Finance
Beam Therapeutics Inc Azioni (BEAM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):